VSee Health cuts reverse split ratio and ends equity purchase deal

VSee Health, Inc. (NASDAQ: VSEE) announced it has terminated a previously disclosed standby equity purchase agreement and revised the maximum ratio of a proposed reverse stock split from 250-for-1 to 80-for-1, according to a company press release.

The reverse stock split remains subject to shareholder approval at the company's upcoming Annual Meeting and applicable regulatory requirements. VSee said its board intends to implement the lowest split ratio necessary to satisfy Nasdaq's continued listing requirements if the measure is approved.

As of July 6, 2026, VSee had 55,679,813 shares of common stock outstanding. The company said it has used non-dilutive financing over the past 45 days and has no active equity financing facility expected to result in near-term dilution.

CEO Dr. Imoigele Aisiku said in a statement: "We have also taken the necessary steps to maintain our Nasdaq listing by asking shareholders to consider a potential reverse stock split at our upcoming Annual Meeting. If approved, the Board intends to implement the lowest reverse split ratio necessary to satisfy Nasdaq's continued listing requirements while preserving shareholder value."

You May Also Be Interested In

• Ernexa Therapeutics adds David Polinsky to its board of directors
• Silver Spruce Resources, Inc. Announces New Chief Financial Officer
• VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset